Acute lymphoblastic leukemia/lymphoma (ALL) encompasses a group of neoplasms composed of immature, precursor B (pre-B) or T (pre-T) lymphocytes referred to as lymphoblasts. The
majority (~85%) of ALLs are precursor B-cell tumors that typically manifest as childhood acute "leukemias" with extensive bone marrow and variable peripheral blood involvement. The
less common precursor T-cell ALLs tend to present in adolescent males as "lymphomas," often with thymic involvement. It is worth noting, however, that there is considerable overlap in
the clinical behavior of precursor B-cell and T-cell ALL; for example, pre-B cell tumors uncommonly present as "lymphomas," and many pre-T cell tumors evolve to a leukemic peripheral
blood picture. Malignant pre-B and pre-T lymphoblasts are also morphologically indistinguishable, and subclassification of ALL is thus dependent on immunophenotyping. Because of
their morphologic and clinical similarities, the various forms of ALL will be considered here together.
Approximately 2500 new cases of ALL are diagnosed each year in the United States, most cases occurring in individuals younger than 15 years of age. ALL is almost twice as common in
whites as in nonwhites and is slightly more frequent in boys than in girls. The incidence of pre-B ALL is highest at about the age of 4, perhaps because the number of normal bone marrow
pre-B lymphoblasts (the cell of origin) peaks in early childhood. Similarly, the peak incidence of pre-T ALL is in adolescence, the age when the thymus reaches its maximal size. Both pre-
B and pre-T ALL occur in adults of all ages, but much less frequently than in children.
Morphology.
Because of different responses to chemotherapeutic agents, it is of great practical importance to distinguish ALL from acute myelogenous leukemia (AML), a neoplasm of immature
myeloid cells that may cause identical signs and symptoms. Compared to myeloblasts, lymphoblasts have condensed chromatin, inconspicuous nucleoli, and scant agranular cytoplasm
( Fig. 14-5A ). However,
TABLE 14-4-- Summary of Major Types of Lymphoid Neoplasms
Diagnosis Cell of Origin Genotype Salient Clinical Features
Neoplasms of immature B and T cells
Precursor B-cell acute
lymphoblastic leukemia/
lymphoma
Bone marrow precursor B-cell
expressing TdT and lacking
surface Ig
Diverse chromosomal translocations; t(12;21) involving
CBFa and ETV6 most common rearrangement
Predominantly children with symptoms relating to
pancytopenia secondary to marrow involvement; aggressive
Precursor T-cell acute
lymphoblastic leukemia/
lymphoma
Precursor T-cell (often of thymic
origin) expressing TdT
Diverse chromosomal translocations, many involving Tcell
receptor loci; rearrangements of TAL1 most
common
Predominantly adolescent males with thymic masses;
variable splenic, hepatic, and bone marrow involvement;